Crucible · Firm report card
Ariad Pharmaceuticals, Inc.
MA · SBIR awardee across 1 federal program (HHS/NIH), first award 1993.
3SBIR awards
$650,000SBIR $
2 → 1Phase I → II
$3M+Follow-on federal $
100+Follow-on contracts
SBIR awards by program
| Program | Awards | SBIR $ | Phase I | Phase II |
|---|---|---|---|---|
| HHS/NIH | 3 | $650,000 | 2 | 1 |
Mission areas
Open the interactive profile of Ariad Pharmaceuticals, Inc. →Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.
Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Follow-on figures for this firm are floors: USAspending is queried for its 100 largest contracts, and this firm reaches that cap. Methodology